Aloe vera leaf

Generic Name
Aloe vera leaf
Brand Names
Alcortin A, Aloquin
Drug Type
Biotech
Chemical Formula
-
CAS Number
8001-97-6
Unique Ingredient Identifier
ZY81Z83H0X
Background

Aloe describes a genus including over 500 species of flowering succulent plants that grow in the Southern peninsula and various islands. Aloe vera, or Aloe barbadensis miller, is the most common species of Aloe that is cultivated for agricultural and medical purposes. It is a perennial succulent xerophyte with elongated leaves that contain a clear gel. While...

Indication

Indicated for use as a topical agent to soothe sensitive skin and to relieve symptoms of various skin conditions, including contact or atopic dermatitis, eczema, dermatitis and acne urticata, first- and second-degree burns, radiation dermatitis, and sunburn.

Associated Conditions
Acne, Atopic Dermatitis, Contact dermatitis and other eczema, Dermatosis, Folliculitis, Intertrigo, Lichen simplex chronicus, Moniliasis, Nummular Dermatitis, Pruritus Ani, Pyoderma, Stasis dermatitis, Disseminated Neurodermatitis, Genital pruritus, Localized Neurodermatitis
Associated Therapies
-
nature.com
·

Herbal extracts in orofacial pain: a systematic review and direct and indirect meta-analysis

7709 studies identified, 62 included after deduplication and assessment. Most studies were blinded with sample sizes ranging from 15 to 270 patients. 70 different plants from 44 families were identified. Risk of bias assessment showed 27 studies with concerns, 22 with low risk, and 13 with high risk. 62 papers identified 17 orofacial pain conditions categorized into six groups. Meta-analyses found herbal extracts more effective in reducing periodontal, oral surgery, oral neuropathic, endodontic, oral mucosal, and TMD pain compared to standard therapies.
globenewswire.com
·

Global Dermatology Drugs Market to Worth Over US$ 50.42

The global dermatology drugs market is projected to reach $50.42 billion by 2032 from $19.71 billion in 2023, driven by innovations in AI, genomics, and personalized medicine. Key players like Novartis, Pfizer, and Johnson & Johnson lead with advanced treatments, while Europe's high prevalence of skin conditions and robust healthcare infrastructure support market growth.
© Copyright 2024. All Rights Reserved by MedPath